Filing Details
- Accession Number:
- 0001181431-14-030477
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-08-28 19:54:24
- Reporting Period:
- 2014-08-26
- Filing Date:
- 2014-08-28
- Accepted Time:
- 2014-08-28 19:54:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1011835 | Medivation Inc. | MDVN | Pharmaceutical Preparations (2834) | 133863260 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1327111 | Lynn Seely | C/O Medivation, Inc. 525 Market St., 36Th Floor San Francisco CA 94105 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-08-26 | 5,700 | $10.59 | 64,722 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-08-26 | 5,700 | $88.95 | 59,022 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2014-08-27 | 14,300 | $10.59 | 73,322 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-08-27 | 11,700 | $89.43 | 61,622 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-08-27 | 2,600 | $90.42 | 59,022 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2014-08-26 | 5,700 | $0.00 | 5,700 | $10.59 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2014-08-27 | 14,300 | $0.00 | 14,300 | $10.59 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
194,300 | 2017-10-01 | No | 4 | M | Direct | |
180,000 | 2017-10-01 | No | 4 | M | Direct |
Footnotes
- Shares sold pursuant to a 10b5-1 Plan.
- The shares were sold at prices ranging from $88.95 to $89.06. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Fully vested.
- The shares were sold at prices ranging from $89.00 to $89.97. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $90.01 to $90.95. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.